The Americas

  • Researchers develop nasally delivered DNA vaccine for tuberculosis

    A research team at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health reports developing a therapeutic intranasal (nose-delivered) DNA vaccine against tuberculosis (TB) that fuses two genes with the goal of directing the immune system to fight drug-tolerant bacterial “persisters” that can survive prolonged antibiotic therapy and contribute to disease relapse. [...]

  • Heart ‘digital twins’ improve arrhythmia outcomes in trial

    Heart digital twins improved ablation outcomes for patients with life-threatening arrhythmias in the first clinical trial of the technology. The research was carried out at Johns Hopkins University in the US. Arrhythmias are abnormal heart rhythms that can be dangerous or fatal. They are typically treated with ablation, which destroys tissue that triggers the irregular [...]

  • US users can now access blood pressure monitoring on Galaxy Watch

    US users can now access blood pressure monitoring on the Galaxy Watch through Samsung’s Health Monitor app. The company said the blood pressure monitoring technology works by calibrating values and changes in blood pressure to give users an estimate of their blood pressure. Wearers can view systolic and diastolic measurements directly on their wrist. [...]

  • WHOOP raises US$575m for personalised health platform

    WHOOP has raised US$575m in Series G funding, valuing the company at US$10.1bn as it expands its personalised health platform globally. The Boston-based company said the funding will support international expansion across Europe, the Gulf states, Latin America and Asia, alongside further growth in the US. WHOOP said it now has more than 2.5m members [...]

  • Tom Brady-backed telehealth firm eMed valued at over US$2 billion

    eMed has been valued at over US$2bn after completing a US$200m Series A round, marking a new milestone for the Miami-based digital healthcare startup. Led by AON Consulting, the round’s investors included retired NFL star Tom Brady, who became the company’s chief wellness officer earlier this year, and Linda Yaccarino, former chief executive of X [...]

  • US healthcare AI plans fall short

    Most US healthcare organisations are falling short on AI plans as hiring demand rises, a report based on data from more than 1,500 employers has found. The report's central finding is that healthcare leaders are aligned on priorities, but execution is lagging. The report, published by Incredible Health, drew on a survey of [...]

  • Doctronic raises US$40m Series B

    Doctronic has raised US$40m in series B funding, marking its third funding round in less than a year. The round was co-led by Abstract and Lightspeed Venture Partners, with participation from existing investors Seven Stars, Union Square Ventures, Tusk Ventures and Mantis. Last year, Doctronic secured a US$20m series A and US$5m from Union Square [...]

  • Third of US adults use AI for health information, survey finds

    About a third of US adults say they use AI chatbots for health information, according to a new survey. The report comes as the use of AI in general grows, alongside concerns among doctors and other healthcare professionals about the quality of health information people are gathering. An American Medical Association survey of US physicians [...]

  • Genentech antibody fails in rare disease trials

    Genentech antibody emugrobart has failed in two rare diseases, raising questions over whether it can preserve muscle in ongoing obesity trials. Roche’s Bay Area subsidiary disclosed the discontinued programmes in separate 19 March letters to the patient communities for spinal muscular atrophy (SMA) and facioscapulohumeral muscular dystrophy (FSHD). For both conditions, Genentech said it had [...]

  • Gifthealth delivers off-the-shelf solution to deliver MFN pricing

    Direct-to-patient programs ready to stand up in as little as 21 days. Gifthealth, the patient access solution that unifies the prescription journey from provider to patient, is deploying direct-to-patient (DTP) programmes to deliver MFN pricing to consumers. Gifthealth is the nation’s largest DTP partner for manufacturers, dispensing more than 90 per cent of current US [...]